Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxcarbazepine 60 mg/ml;  ;   - oral suspension - 60 mg/ml - active: oxcarbazepine 60 mg/ml     excipient: ascorbic acid citrus limon dispersible cellulose macrogol stearate 400 methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - trileptal is indicated in adults and children aged 1 month and above for the treatment of · partial seizures (which include the seizure subtypes of simple, complex and partial seizures evolving to secondarily generalised seizures) and · generalised tonic-clonic seizures. trileptal is indicated as a first-line antiepileptic drug for use as monotherapy or adjunctive therapy. trileptal can replace other antiepileptic drugs when current therapy provides insufficient seizure control.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - oxcarbazepine, quantity: 60 mg/ml - oral liquid, suspension - excipient ingredients: saccharin sodium; propylene glycol; purified water; methyl hydroxybenzoate; sorbitol solution (70 per cent) (non-crystallising); peg-8 stearate; sorbic acid; propyl hydroxybenzoate; ascorbic acid; dispersible cellulose; fragrance (perfume) - for use as monotherapy or adjunctive therapy for the treatment of partial seizures and generalised tonic-clonic seizures, in adults and children.

États-Unis - anglais - NLM (National Library of Medicine)

direct rx - oxcarbazepine (unii: vzi5b1w380) (oxcarbazepine - unii:vzi5b1w380) - oxcarbazepine 300 mg - oxcarbazepine tablets usp are indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and as monotherapy in the treatment of partial seizures in children aged 4 years and above with epilepsy, and as adjunctive therapy in children aged 2 years and above with partial seizures. oxcarbazepine tablets should not be used in patients with a known hypersensitivity to oxcarbazepine or to any of its components. 8.1 pregnancy oxcarbazepine levels may decrease during pregnancy [see warnings and precautions (5.10)]. pregnancy category c there are no adequate and well-controlled clinical studies of oxcarbazepine in pregnant women; however, oxcarbazepine is closely related structurally to carbamazepine, which is considered to be teratogenic in humans. given this fact, and the results of the animal studies described, it is likely that oxcarbazepine is a human teratogen. oxcarbazepine should be used during pregnancy only if the potential benefit justifies the potential risk to the

Irlande - anglais - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - oxcarbazepine - film-coated tablet - 300 milligram(s) - oxcarbazepine

Australie - anglais - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - oxcarbazepine -

Irlande - anglais - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - oxcarbazepine - oral suspension - 60 milligram(s)/millilitre - carboxamide derivatives; oxcarbazepine

Irlande - anglais - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - oxcarbazepine - oral suspension - 60 milligram(s)/millilitre - oxcarbazepine

Malte - anglais - Medicines Authority

novartis pharmaceuticals uk limited frimley business park, frimley camberley, surrey gu16 7sr, united kingdom - oxcarbazepine - film-coated tablet - oxcarbazepine 150 mg - antiepileptics

Malte - anglais - Medicines Authority

novartis pharmaceuticals uk limited frimley business park, frimley camberley, surrey gu16 7sr, united kingdom - oxcarbazepine - film-coated tablet - oxcarbazepine 300 mg - antiepileptics

Malte - anglais - Medicines Authority

novartis pharmaceuticals uk limited frimley business park, frimley camberley, surrey gu16 7sr, united kingdom - oxcarbazepine - film-coated tablet - oxcarbazepine 600 mg - antiepileptics